Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Retained Earnings (2018 - 2025)

Historic Retained Earnings for Precision Biosciences (DTIL) over the last 8 years, with Q3 2025 value amounting to -$548.3 million.

  • Precision Biosciences' Retained Earnings fell 1798.98% to -$548.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$548.3 million, marking a year-over-year decrease of 1798.98%. This contributed to the annual value of -$482.5 million for FY2024, which is 146.38% up from last year.
  • As of Q3 2025, Precision Biosciences' Retained Earnings stood at -$548.3 million, which was down 1798.98% from -$526.5 million recorded in Q2 2025.
  • Over the past 5 years, Precision Biosciences' Retained Earnings peaked at -$283.1 million during Q2 2021, and registered a low of -$548.3 million during Q3 2025.
  • Its 5-year average for Retained Earnings is -$425.5 million, with a median of -$453.4 million in 2023.
  • In the last 5 years, Precision Biosciences' Retained Earnings plummeted by 4946.42% in 2021 and then skyrocketed by 364.72% in 2024.
  • Over the past 5 years, Precision Biosciences' Retained Earnings (Quarter) stood at -$316.7 million in 2021, then crashed by 35.25% to -$428.3 million in 2022, then fell by 14.32% to -$489.6 million in 2023, then rose by 1.46% to -$482.5 million in 2024, then decreased by 13.65% to -$548.3 million in 2025.
  • Its Retained Earnings was -$548.3 million in Q3 2025, compared to -$526.5 million in Q2 2025 and -$503.0 million in Q1 2025.